Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study of Rituximab (Mabthera) in Patients With Relapsed Follicular Lymphoma Prior to High-Dose Therapy as In Vivo Purging and to Maintain Remission Following High-Dose Therapy

NCT00005589 is registered in ClinicalTrials.gov with EBMT Solid Tumors Working Party as lead sponsor.

NCT NCT00005589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study of Rituximab (Mabthera) in Patients With Relapsed Follicular Lymphoma Prior to High-Dose Therapy as In Vivo Purging and to Maintain Remission Following High-Dose Therapy
Lead sponsor
EBMT Solid Tumors Working Party
Phase
Phase 3
Overall status
Completed
Start date
October 31, 1999
Completion date
April 30, 2013
Enrollment
460 (estimated)
Sites
131

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma